We herein report a 79-year-old woman with subacute progressive ataxic sensory neuropathy. The patient's symptoms began with numbness in the lower extremities, which rapidly deteriorated, resulting in gait disturbance and abnormal sensations in the extremities, reaching a peak over a period of approximately two months. Nerve conduction studies revealed pure axonal-type sensory polyneuropathy. The expeditious progression of the disease initially prompted suspicion of Guillain-Barré syndrome or paraneoplastic syndrome. Nevertheless, after comprehensive evaluations, the conclusive diagnosis was confirmed as ataxic sensory neuropathy with Sjögren's syndrome. Intensive immunotherapy was administered; however, it was ineffective in halting disease progression. Consequently, this case underscores the significance of an early comprehensive diagnosis and prompt immunotherapy for ataxic sensory neuropathy associated with Sjögren's syndrome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11189695PMC
http://dx.doi.org/10.2169/internalmedicine.2226-23DOI Listing

Publication Analysis

Top Keywords

ataxic sensory
16
sensory neuropathy
16
sjögren's syndrome
12
subacute progressive
8
neuropathy sjögren's
8
sensory
5
syndrome
5
progressive severe
4
ataxic
4
severe ataxic
4

Similar Publications

Antimyelin-associated glycoprotein (MAG) neuropathy is a rare autoimmune demyelinating peripheral neuropathy caused by IgM autoantibodies targeting MAG. The typical presentation is that of a slowly progressive, distal, length-dependent, predominantly sensory, sometimes ataxic neuropathy, frequently accompanied by upper limb tremor. Distal motor weakness may subsequently occur.

View Article and Find Full Text PDF

Background: Pure mesencephalic infarcts are uncommon, the main clinical manifestations being oculomotor signs and ataxia.

Objectives: Primary objective was to determine the incidence of pure midbrain strokes. We also evaluated the clinical spectrum, syndromes, arterial territories involved, risk factors, and outcome at 3 months.

View Article and Find Full Text PDF
Article Synopsis
  • Autoimmune neuropathies are disorders where the immune system attacks peripheral nerves, with Guillain-Barré syndrome (GBS) as a common acute form, and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) as a chronic form.
  • Recent discoveries of specific antibodies associated with nerve damage have changed diagnostic and treatment approaches for GBS and CIDP, making testing for certain antibodies more common.
  • New subtypes of autoimmune neuropathies, defined by antibodies affecting the nodes of Ranvier, have emerged, allowing for better patient classification and targeted therapies, such as anti-CD20 treatment.
View Article and Find Full Text PDF

Introduction: Ubiquitin C-terminal hydrolase L1 (UCHL1) has been associated with a severe, complex autosomal recessive spastic paraplegia (HSP79) [1] [2] [3] [4]. More recently, UCHL1 loss of function (LoF) variants have been associated to an autosomal dominant disease characterized by late-onset spastic ataxia, neuropathy, and frequent optic atrophy [5].

Methods: Routine clinical care whole-genome (WGS) and exome (ES) sequencing.

View Article and Find Full Text PDF

Sjögren's syndrome is often accompanied by various neurological complications, among which peripheral neuropathy is the most common. A variety of clinical phenotypes of peripheral neuropathy, including axonal polyneuropathy and sensory ataxic neuropathy are reported in the literature. We present an overview of the pathophysiology and differential diagnosis of each phenotype.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!